Patent ID: 8748386

Claim:
A method of treating Alzheimer's disease or other tauopathy in a subject, or of reducing the severity of Alzheimer's disease or said other tauopathy in said subject, said method comprising: administering to said subject an immunogenic tau peptide (I) whose amino acid sequence consists of: (a) the amino acid sequence of SEQ ID NO:57; (b) an amino acid sequence selected from the group consisting of SEQ ID NO:13 and SEQ ID NO:42; (c) an amino acid sequence selected from the group consisting of SEQ ID NO:74 and SEQ ID NO:99; (d) an amino acid sequence selected from the group consisting of SEQ ID NO:5 and SEQ ID NO:34; and (e) an amino acid sequence selected from the group consisting of SEQ ID NO:23 and SEQ ID NO:52; wherein said immunogenic tau peptide (I) peptide is administered in an amount sufficient to elicit an active immune response in said subject to said immunogenic tau peptide; and wherein said elicited active immune response provides said subject with treatment of Alzheimer's disease or said other tauopathy or reduces the severity of Alzheimer's disease or said other tauopathy in said subject.